Dice Therapeutics Inc (DICE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -18,591 | -48,959 | -32,764 | -15,429 | -8,066 |
| Depreciation Amortization | 548 | 768 | 583 | 414 | 180 |
| Accounts payable and accrued liabilities | 3,054 | -772 | 1,363 | -692 | -294 |
| Other Working Capital | 1,741 | 1,647 | 1,864 | -1,840 | -451 |
| Other Operating Activity | -916 | 8,024 | 4,074 | 1,591 | 633 |
| Operating Cash Flow | $-14,164 | $-39,292 | $-24,880 | $-15,956 | $-7,998 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -385 | -718 | -522 | -401 | -365 |
| Purchase Of Investment | -65,506 | -218,471 | -26,971 | -26,956 | -24,082 |
| Sale Of Investment | 18,005 | 14,565 | 2,700 | N/A | N/A |
| Investing Cash Flow | $-47,886 | $-204,624 | $-24,793 | $-27,357 | $-24,447 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 2,416 | 2,416 | 2,416 | N/A |
| Debt Repayment | N/A | -99 | -99 | -65 | -32 |
| Common Stock Issued | 84 | 214,707 | 216,182 | N/A | N/A |
| Other Financing Activity | -192 | 83,230 | 83,296 | -3,021 | -2,491 |
| Financing Cash Flow | $-108 | $300,254 | $301,795 | $-670 | $-2,523 |
| Beginning Cash Position | 116,174 | 59,836 | 59,836 | 59,836 | 59,836 |
| End Cash Position | 54,016 | 116,174 | 311,958 | 15,853 | 24,868 |
| Net Cash Flow | $-62,158 | $56,338 | $252,122 | $-43,983 | $-34,968 |
| Free Cash Flow | |||||
| Operating Cash Flow | -14,164 | -39,292 | -24,880 | -15,956 | -7,998 |
| Capital Expenditure | -385 | -718 | -522 | -401 | -365 |
| Free Cash Flow | -14,549 | -40,010 | -25,402 | -16,357 | -8,363 |